Spain Set to Become First Country to Apply Gene Therapy for Fanconi Anemia

Spain is poised to become the first country globally to implement gene therapy for Fanconi anemia, a rare hereditary disorder that damages bone marrow function and reduces blood cell production. This genetic condition also causes congenital malformations and significantly increases the risk of developing certain cancers. The approval of this groundbreaking therapy represents a major milestone in treating rare blood disorders and offers hope to patients with limited treatment options. Gene therapy works by correcting the faulty genes responsible for the disease, potentially providing long-term benefits for affected individuals and their families.